Drug Development in Low- and Middle-Income Countries: Opportunity or Exploitation?

Jalali, Rakesh; Nogueira-Rodrigues, Angelica; Das, Arunangshu; Sirohi, Bhawna; Panda, Pankaj Kumar

Jalali, Rakesh; Nogueira-Rodrigues, Angelica; Das, Arunangshu; Sirohi, Bhawna; Panda, Pankaj Kumar.

Affiliation

Jalali R; Neuro-Oncology Cancer Management Team, Apollo Proton Cancer Centre, Taramani, Chennai, India.
Nogueira-Rodrigues A; Federal University of Minas Gerais, DOM Oncologia, Grupo Oncoclínicas, EVA Brazilian Group of Gynecologic Cancer, LACOG, Porto Alegre, Brazil.
Das A; Department of Oncology, Square Hospitals Ltd, Dhaka, Bangladesh.
Sirohi B; Department of Medical Oncology, Apollo Proton Cancer Centre, Taramani, Chennai, India.
Panda PK; Clinical Research Secretariat, Apollo Proton Cancer Centre, Taramani, Chennai, India.

Am Soc Clin Oncol Educ Book ; 42: 1-8, 2022 Apr.

Article in En | MEDLINE | ID: mdl-35658520

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Development / Neoplasms Type of study: Prognostic_studies Aspects: Determinantes_sociais_saude Limits: Humans Language: En Journal: Am Soc Clin Oncol Educ Book Year: 2022 Document type: Article Affiliation country: India Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google